Xtant Medical Holdings, Inc.
AMEX:XTNTMedical - Devices
-$0.00 today
- Market cap
- $50.37M
- Beta
- -0.17
- P/E (TTM)
- 33.4
- EPS (TTM)
- $0.01
Volume 0.16M
Average 0.16M
XTNT Deferred Revenue
Payments received for goods or services the company will deliver within the next year.
Xtant Medical Holdings, Inc.AMEX: XTNT
Deferred Revenue · Q1 FY2026 · quarter ended Mar 2026
Deferred revenue remains negative
Q1 FY2026 deferred revenue was $0, compared with $0 a year earlier.
Context
- Deferred revenue amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Deferred revenue increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Deferred Revenue history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Deferred Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Deferred Revenue vs competitors
How XTNT compares with its peers on the latest reported figures
- XTNT's Mar 2026 deferred revenue of $0 is the 4th highest of the 8 companies compared; the peer median is $0.
- Deferred revenue amounts to 0.0% of total assets for XTNT, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $6.63M | +8.9% | +0.2% | 10.6% | |
| Mar 2026 | $5.11M | +1.9% | +3.9% | 2.3% | |
| Mar 2026 | $714K | +66.0% | — | 1.1% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
EXOZeXoZymes, Inc. | Mar 2026 | $0 | — | — | 0.0% |
| Peer median (excluding XTNT) | $0 | +8.9% | +2.1% | 0.0% | |
Competitors are the stored peer set for XTNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 18.24M | 20.3M | 5.72M | 6.2M | 17.05M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 7.15M | 10.85M | 20.73M | 20.66M | 17.8M |
| Inventory | 17.95M | 17.29M | 36.89M | 38.63M | 30.26M |
| Other Current Assets | 144K | 882K | 1.54M | 1.62M | 13.13M |
| Total Current Assets | 44.33M | 49.32M | 64.87M | 67.12M | 78.25M |
| Property, Plant & Equipment (Net) | 6.47M | 7.17M | 10.22M | 10.96M | 9.39M |
| Goodwill | 3.21M | 3.21M | 7.3M | 7.3M | 6.07M |
| Intangible Assets | 400K | 344K | 10.09M | 8.36M | 299K |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 287K | 197K | 141K | 103K | 133K |
| Total Non-current Assets | 10.36M | 10.91M | 27.74M | 26.72M | 15.9M |
| Total Assets | 54.69M | 60.23M | 92.61M | 93.84M | 94.15M |
| Account Payables | 2.62M | 3.49M | 7.05M | 7.92M | 3.84M |
| Short-term Debt | 3.62M | 5.71M | 4.62M | 12.12M | 14.36M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.18M | 4.46M | 0 | 5.57M | 0 |
| Total Current Liabilities | 11.08M | 15.22M | 22.99M | 28.58M | 29.48M |
| Long-term Debt | 11.79M | 9.69M | 17.17M | 22.04M | 11.03M |
| Deferred Tax Liabilities | 0 | 0 | 21K | 42K | 5K |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 210K | 0 | 0 |
| Total Non-current Liabilities | 12.73M | 10.84M | 18.27M | 22.29M | 13.71M |
| Total Liabilities | 23.81M | 26.06M | 41.26M | 50.87M | 43.19M |
| Common Stock | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | (235.19M) | (243.67M) | (243.01M) | (259.46M) | (254.49M) |
| Accumulated OCI | 0 | 0 | 29K | (316K) | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 30.88M | 34.17M | 51.35M | 42.96M | 50.95M |
| Total Debt | 16.85M | 17.07M | 23.56M | 35.14M | 28.72M |
| Net Debt | (1.4M) | (3.23M) | 17.84M | 28.94M | 11.66M |
Xtant Medical Holdings, Inc.
AMEX:XTNT
Intrinsic Alpha fair value
Locked
Current Price
$0.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.